Complete response to temozolomide in chronic lymphocytic leukemia

We report a case of incidentally diagnosed chronic lymphocytic leukemia (CLL) in a patient with glioblastoma, which responded completely following standard treatment of the glioblastoma with temozolomide and cranial irradiation. The patient remained without an evidence of CLL until his death from re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Archana, Ramani, Nisha, Stoppacher, Robert, Coyle, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494405/
https://www.ncbi.nlm.nih.gov/pubmed/28680610
http://dx.doi.org/10.1002/ccr3.978
_version_ 1783247672730189824
author Rao, Archana
Ramani, Nisha
Stoppacher, Robert
Coyle, Thomas
author_facet Rao, Archana
Ramani, Nisha
Stoppacher, Robert
Coyle, Thomas
author_sort Rao, Archana
collection PubMed
description We report a case of incidentally diagnosed chronic lymphocytic leukemia (CLL) in a patient with glioblastoma, which responded completely following standard treatment of the glioblastoma with temozolomide and cranial irradiation. The patient remained without an evidence of CLL until his death from recurrent glioblastoma. Further study of temozolomide for the treatment of CLL is indicated.
format Online
Article
Text
id pubmed-5494405
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54944052017-07-05 Complete response to temozolomide in chronic lymphocytic leukemia Rao, Archana Ramani, Nisha Stoppacher, Robert Coyle, Thomas Clin Case Rep Case Reports We report a case of incidentally diagnosed chronic lymphocytic leukemia (CLL) in a patient with glioblastoma, which responded completely following standard treatment of the glioblastoma with temozolomide and cranial irradiation. The patient remained without an evidence of CLL until his death from recurrent glioblastoma. Further study of temozolomide for the treatment of CLL is indicated. John Wiley and Sons Inc. 2017-05-31 /pmc/articles/PMC5494405/ /pubmed/28680610 http://dx.doi.org/10.1002/ccr3.978 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Rao, Archana
Ramani, Nisha
Stoppacher, Robert
Coyle, Thomas
Complete response to temozolomide in chronic lymphocytic leukemia
title Complete response to temozolomide in chronic lymphocytic leukemia
title_full Complete response to temozolomide in chronic lymphocytic leukemia
title_fullStr Complete response to temozolomide in chronic lymphocytic leukemia
title_full_unstemmed Complete response to temozolomide in chronic lymphocytic leukemia
title_short Complete response to temozolomide in chronic lymphocytic leukemia
title_sort complete response to temozolomide in chronic lymphocytic leukemia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494405/
https://www.ncbi.nlm.nih.gov/pubmed/28680610
http://dx.doi.org/10.1002/ccr3.978
work_keys_str_mv AT raoarchana completeresponsetotemozolomideinchroniclymphocyticleukemia
AT ramaninisha completeresponsetotemozolomideinchroniclymphocyticleukemia
AT stoppacherrobert completeresponsetotemozolomideinchroniclymphocyticleukemia
AT coylethomas completeresponsetotemozolomideinchroniclymphocyticleukemia

Ejemplares similares